GeneMedi's Pathway Assays portfolio for drug discovery and mechanism of action (MOA) research.
GeneMedi's Pathway portfolio offers a range of kits designed to facilitate the study of intracellular and extracellular signaling pathways. Pathways are complex series of molecular interactions that regulate cellular functions and contribute to the development and progression of diseases. These pathways play a critical role in the regulation of various biological processes, including cell signaling, metabolism, and gene expression. The identification and targeting of specific pathways and their associated signaling molecules have led to the development of several diagnostic and therapeutic applications. For instance, pathways are involved in the pathogenesis of many diseases, including cancer, neurodegenerative diseases, metabolic disorders, and others, and are, therefore, attractive targets for drug development.
Several classifications of pathways exist, based on their structural and functional properties. One widely used classification divides pathways into two primary categories, namely intracellular and extracellular pathways. Each classification of pathway comprises several important proteins with distinct functions and therapeutic applications. For example, intracellular pathways include the MAPK pathway, PI3K pathway, and Wnt/beta-catenin pathway that are involved in cell signaling, regulation of cell cycle progression, and immune responses. Extracellular pathways include the cytokine signaling pathway, TGF-beta signaling pathway, and FGF signaling pathway, which are involved in the regulation of cell proliferation, differentiation, and survival. In addition, the abnormal activation or inhibition of certain pathways has been linked to the development and progression of disease, and their detection can be used for early diagnosis and prognosis.
GeneMedi provides researchers with benchmark antibodies, including monoclonal antibodies (mAbs) expressed using mammalian cell lines. These antibodies offer high quality and reproducibility and can be used as reference therapeutic antibodies in cell culture, assay development, animal model development, PK/PD model development (pharmacokinetics & pharmacodynamic), and MOA research for biological drug discovery. Overall, pathways represent a diverse and attractive class of therapeutic targets with significant potential in drug discovery and development. The complex signaling pathways and functions of such pathways make them highly relevant in both diagnostics and therapeutics, with the classification and identification of distinct pathways offering opportunities for precision medicine and personalized therapies.
Q1. What are pathways?
A1: Pathways are a series of molecular interactions that regulate cellular functions and contribute to the development and progression of diseases.
Q2. Why are pathways important in drug discovery?
A2: Pathways are a critical target for drug discovery in the pharmaceutical industry because they are involved in regulating various biological processes, including cell signaling and metabolism, which play a key role in disease development and progression.
Q3. What are the two primary categories of pathways?
A3: The two primary categories of pathways are intracellular pathways and extracellular pathways, which comprise several important proteins with distinct functions and therapeutic applications.
Q4. What are benchmark antibodies?
A4: Benchmark antibodies are reference therapeutic antibodies used in drug discovery and various research applications, including assay development, animal model development, and mechanism of action research.
Q5. What diseases are pathways linked to?
A5: Abnormal activation or inhibition of certain pathways has been linked to the development and progression of many diseases, including cancer, neurodegenerative diseases, metabolic disorders, and others.